Bayer CropScience Ltd Q2 FY26 results (latest), Jul–Sep 2025 →Revenue ₹1,553 Cr −10.6% YoYSee revenue, profit and what management said. You are viewing Q2 FY21.
BC

Bayer CropScience Ltd

Q2 FY21Fertilizers & Agrochemicals

Bayer CropScience Q2 FY21 earnings call: Revenue & Margins

Q2 FY21 investor presentation: what the company reported on revenue, margins and capex.

Bayer CropScience Ltd Q2 FY21 key numbers

Revenue
Revenue from Operations for Q2: ₹13,816 million, a 3% increase year-on-year.

As stated in Bayer CropScience Ltd's Q2 FY21 investor presentation · published 24 Sept 2026. Reported figures, not investment advice.

Based on Bayer CropScience Ltd's Q2 FY21 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.

Price₹3,736
Market cap₹17.0K Cr
P/E23.2

The short version

Revenue from Operations for Q2: ₹13,816 million, a 3% increase year-on-year. However, for the first nine months of 2020, EBITDA before special items is €9,069 million, up +0.8% YoY (Page 5). - Profit before exceptional items and tax for Q2 is ₹6,098 million (Page 7).

From Bayer CropScience Ltd's Q2 FY21 earnings-call transcript · updated 24 Sept 2026.

Revenue & Sales Performance

  • Revenue from Operations for Q2: ₹13,816 million, a 3% increase year-on-year.
  • Half Year (H1) Revenue: ₹26,094 million, up 14% compared to previous year.
  • Growth driven by early sowing, good monsoon, combined distribution strength, higher acreages, and positive commodity prices.

2 more points from Bayer CropScience Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Bayer CropScience Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

See what Bayer CropScience Ltd said on capital expenditure plans — free account, 30 seconds.

Top-ranked in Fertilizers & Agrochemicals

Ranked on what management guided this quarter

Guidance-ranked
1Anya Polytech &
Rev 2Mar 1
Rev 2Mar 2
3
Rev 2Mar 3
4
Rev 2Mar 3
5
Rev 3Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Bayer CropScience Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

Based on the content provided: - Focus is on cash generation through collections rather than explicit order backlog figures. - There is mention of growth in Crop Protection (CP) due to early placement and supply advantages. - The financial and business updates focus on revenue, cash flow, profitability, synergies, and operational performance.

Bayer CropScience Ltd — Quarterly revenue & net profit

Revenue Net profit
Dec 2024Q3 FY25
Mar 2025Q4 FY25
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26

Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹1.1K Cr, net profit ₹162 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Bayer CropScience Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Bayer CropScience Ltd Q2 FY21 results?

Revenue from Operations for Q2: ₹13,816 million, a 3% increase year-on-year. However, for the first nine months of 2020, EBITDA before special items is €9,069 million, up +0.8% YoY (Page 5). - Profit before exceptional items and tax for Q2 is ₹6,098 million (Page 7).

What is Bayer CropScience Ltd share price analysis?

Bayer CropScience Ltd currently shows a neutral. The stock trades at a P/E of 23.2 with a market cap of ₹16,986 Cr. Investors should review the full earnings analysis for detailed insights.

Keep Bayer CropScience Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.